← Back to directory

Vincent Chi‐Chung Cheng

Researcher Next ID · RN-028243

Researcher · Medicine

Queen Mary Hospital

Hong Kong, Taiwan

Not currently recruitingFunding unknown
Works count
507
Citation count
44,368
H-index
84
i10-index
330

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
SARS-CoV-2 and COVID-19 Research
Infection Control and Ventilation
Respiratory viral infections research
COVID-19 Clinical Research Studies
Antibiotic Resistance in Bacteria

Publications

  • Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic

    Emerging Microbes & Infections · 2021 · 10.1080/22221751.2021.1898291

  • Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients

    Clinical Infectious Diseases · 2021 · 10.1093/cid/ciab1041

  • Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic

    Emerging Microbes & Infections · 2021 · 10.1080/22221751.2021.1898291

  • Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients

    Clinical Infectious Diseases · 2021 · 10.1093/cid/ciab1041

  • Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing

    Clinical Infectious Diseases · 2020 · https://doi.org/10.1093/cid/ciaa1275

  • Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)

    Clinical Infectious Diseases · 2020 · https://doi.org/10.1093/cid/ciaa478

  • Consistent Detection of 2019 Novel Coronavirus in Saliva

    Clinical Infectious Diseases · 2020 · https://doi.org/10.1093/cid/ciaa149

  • Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens

    Journal of Clinical Microbiology · 2020 · https://doi.org/10.1128/jcm.00310-20

  • A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

    The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)30154-9

  • Transmission of Rat Hepatitis E Virus Infection to Humans in Hong Kong: A Clinical and Epidemiological Analysis

    Hepatology · 2020 · https://doi.org/10.1002/hep.31138

  • Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

    The Lancet Infectious Diseases · 2020 · 10.1016/s1473-3099(20)30196-1

  • Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

    The Lancet · 2020 · 10.1016/s0140-6736(20)31042-4

  • The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2

    Journal of Infection · 2020 · 10.1016/j.jinf.2020.04.024

  • Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19)

    Clinical Infectious Diseases · 2020 · 10.1093/cid/ciaa644

  • Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong

    Infection Control and Hospital Epidemiology · 2020 · 10.1017/ice.2020.58

  • Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

    The Lancet Infectious Diseases · 2020 · 10.1016/s1473-3099(20)30196-1

  • Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

    The Lancet · 2020 · 10.1016/s0140-6736(20)31042-4

  • The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2

    Journal of Infection · 2020 · 10.1016/j.jinf.2020.04.024

  • Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19)

    Clinical Infectious Diseases · 2020 · 10.1093/cid/ciaa644

  • Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong

    Infection Control and Hospital Epidemiology · 2020 · 10.1017/ice.2020.58

  • Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant

    Emerging infectious diseases · 2018 · https://doi.org/10.3201/eid2412.180937

  • Zika fever and congenital Zika syndrome: An unexpected emerging arboviral disease

    Journal of Infection · 2016 · 10.1016/j.jinf.2016.02.011

  • Zika fever and congenital Zika syndrome: An unexpected emerging arboviral disease

    Journal of Infection · 2016 · 10.1016/j.jinf.2016.02.011

  • Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease

    Clinical Microbiology Reviews · 2015 · https://doi.org/10.1128/cmr.00102-14

  • Differential Cell Line Susceptibility to the Emerging Novel Human Betacoronavirus 2c EMC/2012: Implications for Disease Pathogenesis and Clinical Manifestation

    The Journal of Infectious Diseases · 2013 · https://doi.org/10.1093/infdis/jit123

  • Delayed Clearance of Viral Load and Marked Cytokine Activation in Severe Cases of Pandemic H1N1 2009 Influenza Virus Infection

    Clinical Infectious Diseases · 2010 · 10.1086/650581

  • Delayed Clearance of Viral Load and Marked Cytokine Activation in Severe Cases of Pandemic H1N1 2009 Influenza Virus Infection

    Clinical Infectious Diseases · 2010 · 10.1086/650581

  • Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection

    Clinical Microbiology Reviews · 2007 · https://doi.org/10.1128/cmr.00023-07

  • Coronavirus HKU1 and Other Coronavirus Infections in Hong Kong

    Journal of Clinical Microbiology · 2006 · https://doi.org/10.1128/jcm.02614-05

  • Clinical and Molecular Epidemiological Features of Coronavirus HKU1–Associated Community‐Acquired Pneumonia

    The Journal of Infectious Diseases · 2005 · https://doi.org/10.1086/497151

  • In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds

    Journal of Clinical Virology · 2004 · 10.1016/j.jcv.2004.03.003

  • Detection of SARS Coronavirus in Patients with Suspected SARS

    Emerging infectious diseases · 2004 · https://doi.org/10.3201/eid1002.030610

  • Viral Loads in Clinical Specimens and SARS Manifestations

    Emerging infectious diseases · 2004 · https://doi.org/10.3201/eid1009.040058

  • In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds

    Journal of Clinical Virology · 2004 · 10.1016/j.jcv.2004.03.003

  • Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

    The Lancet · 2003 · 10.1016/s0140-6736(03)13412-5

  • Coronavirus as a possible cause of severe acute respiratory syndrome

    The Lancet · 2003 · 10.1016/s0140-6736(03)13077-2

  • Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

    The Lancet · 2003 · 10.1016/s0140-6736(03)13412-5

  • Coronavirus as a possible cause of severe acute respiratory syndrome

    The Lancet · 2003 · 10.1016/s0140-6736(03)13077-2

  • Clinical Spectrum of Paradoxical Deterioration During Antituberculosis Therapy in Non-HIV-Infected Patients

    European Journal of Clinical Microbiology & Infectious Diseases · 2002 · https://doi.org/10.1007/s10096-002-0821-2

Current projects

    No projects listed.